ArticleMedical physics2026
Correlation of ultrasound attenuation with proton density fat fraction across multiple organs in healthy volunteers.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundLocal determination of the attenuation in biological tissues has been the focus of extensive research over the past decades. Its characterization is of major interest for both noninvasive thermal therapies and diagnostic applications. Numerous ultrasound (US)-based methods have been investigated in recent years to assess attenuation in vivo. PURPOSE: In this article, we aim to map US attenuation in four organs of human volunteers: liver, pancreas, kidney, and breast. We propose to compare the mean attenuation values obtained in each tissue with the corresponding proton density fat fraction (PDFF) derived from quantitative magnetic resonance imaging (qMRI). This comparison allows us to (i) present a direct calculation method of the local US attenuation and (ii) investigate the relationship between the average fat content of each organ and its global US attenuation.
methodsThe ultrasonic measurement method is in line with techniques originating from the spectral difference method. Here, the attenuation coefficient (AC) is estimated by insonifying tissues with a single plane wave and acquiring the backscattered echoes. This approach avoids the need for a reference medium to compensate for diffraction and focusing effects. The method is characterized and validated on a calibrated phantom and compared with two commonly used techniques on ex vivo liver tissues. Subsequently, attenuation maps and average values obtained from US imaging in healthy volunteers are compared with PDFF values measured by qMRI. Hepatic (
resultsMeasurements on the calibrated phantom showed relative errors between the measured mean values and the manufacturer values of 2% and 9%, respectively. Average AC of each organ was included in the confidence interval of the corresponding literature value. The Pearson correlation coefficient between
conclusionsThis work presents an alternative method for in vivo characterization of US attenuation based on the emission of a plane wave, and highlights the impact of fat density on inter-organ attenuation variations. Together, these results provide new insights into the relationship between tissue microstructure and US attenuation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.